SCHEMBL3374256

SCHEMBL3374256

FC1CCN(Cc2ccc(Cl)cc2-c2cccs2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 5/20 0.42
CYP2A13 Q16696 1/20 0.41
CCR5 P51681 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
DRD4 P21917 2/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39
POLB P06746 2/20 0.38
LMNA P02545 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377154 0.86 CYP2A13 (0.58) CYP2A13ALDH1A1HTTRAB9ASMN1; SMN2
SCHEMBL3372885 0.72 KDM4E (0.37) HTTRAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3344984 0.72 NPC1 (0.49) CYP2A13ALDH1A1RAB9ASMN1; SMN2MEN1
SCHEMBL3374752 0.68 DRD2 (0.38) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL9335409 0.66 CNR2 (0.47) ALDH1A1HTTRAB9ASMN1; SMN2MEN1
SCHEMBL3149917 0.66 CXCR3 (0.65) CXCR3
SCHEMBL8116232 0.65 CYP2A13 (0.62) CYP2A13CCR5SIGMAR1ALDH1A1MEN1
SCHEMBL6947104 0.65 CYP2A13 (0.62) CYP2A13CCR5SIGMAR1ALDH1A1MEN1
SCHEMBL1111744 0.65 LTA4H (0.51) ALDH1A1HTTRAB9ASMN1; SMN2MEN1
SCHEMBL15525055 0.65 LTA4H (0.41) CXCR3HTTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010045006-A1 METHYLENE AMINES OF THIENO [2,3-D] PYRIMIDINE AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2010-04-22 WO disclosed